(Q47569014)

4 February 2018

title

VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies. (English)

1 reference

4 February 2018

author

Kari Alitalo

series ordinal

2

1 reference

4 February 2018

author name string

Ulf Eriksson

series ordinal

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 February 2018

published in

Nature Medicine

1 reference

4 February 2018

volume

8

1 reference

4 February 2018

page(s)

775-777

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/nm0802-775

exact match

0 references

cites work

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

VEGF receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Developmental control of blood cell migration by the Drosophila VEGF pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

KDR receptor: a key marker defining hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

inferred from DOI database lookup

7 January 2021

based on heuristic

Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect

1 reference

https://api.crossref.org/works/10.1038%2FNM0802-775

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0802-775

1 reference

4 February 2018

PubMed ID

12152025

1 reference

4 February 2018